EVANIUM
Regensburg-based life-science company developing ingredients based on its IP-protected drug delivery technology OPTISOLV®
EVANIUM has raised €2.2M across 1 funding round from 3 investors, most recently a Seed round in Apr 2026. Based in Regensburg, Germany; active in Healthtech. Data as of 28 Oct 2026.
Regensburg, Germanyevanium.de ↗
Total raised
€2.2M
€2,200,000
Funding rounds
1
Investors
3
distinct backers
Active since
2026-04
latest 2026-04
Funding by year
EUR raised per year · 2026 YTDEVANIUM — funding by year — interactive chart.
Data table
| EVANIUM — funding by year | |
|---|---|
| 2026 | €2.2M |
Signals
High confidenceRaise-next likelihood41
base rate 44% for Seed
- ▲ In typical raise window
- ▼ Low backer re-investment
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-04-15 | Seed | €2.2M | Angel Investors,Feast Ventures,FoodLabs | View deal → |
Investors
3Related news
Similar companies
same sector or country- Delivery Hero€7.1BGermany · E-commerce
- Enpal€4.6BGermany · Cleantech
- Auxmoney€3.5BGermany · Fintech
- Helsing€2.9BGermany · AI
- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
Global coverage: FundingData